Shukla S - Search Results

1

Epigenetic regulation of human retinoblastoma.

Singh U, Malik MA, Goswami S, Shukla S, Kaur J. Singh U, et al. Among authors: shukla s. Tumour Biol. 2016 Nov;37(11):14427-14441. doi: 10.1007/s13277-016-5308-3. Epub 2016 Sep 17. Tumour Biol. 2016. PMID: 27639385 Review.

2

Glutathione S-transferase (GSTM1, GSTT1) polymorphisms and JOAG susceptibility: A case control study and meta-analysis in glaucoma.

Malik MA, Gupta V, Shukla S, Kaur J. Malik MA, et al. Among authors: shukla s. Gene. 2017 Sep 10;628:246-252. doi: 10.1016/j.gene.2017.07.028. Epub 2017 Jul 12. Gene. 2017. PMID: 28710033

3

Expression of multidrug resistance proteins in retinoblastoma.

Shukla S, Srivastava A, Kumar S, Singh U, Goswami S, Chawla B, Bajaj MS, Kashyap S, Kaur J. Shukla S, et al. Int J Ophthalmol. 2017 Nov 18;10(11):1655-1661. doi: 10.18240/ijo.2017.11.04. eCollection 2017. Int J Ophthalmol. 2017. PMID: 29181307 Free PMC article.

4

Vascular endothelial growth factor (VEGF-634G/C) polymorphism and retinopathy of prematurity: a meta-analysis.

Malik MA, Shukla S, Azad SV, Kaur J. Malik MA, et al. Among authors: shukla s. Saudi J Ophthalmol. 2014 Oct;28(4):299-303. doi: 10.1016/j.sjopt.2014.07.001. Epub 2014 Jul 24. Saudi J Ophthalmol. 2014. PMID: 25473347 Free PMC article.

5

Association between VEGF polymorphisms (-460 T/C and +936 C/T) and retinopathy of prematurity risk: A meta-analysis.

Shukla S, Malik MA, Chandra P, Kaur J. Shukla S, et al. Saudi J Ophthalmol. 2016 Jul-Sep;30(3):157-162. doi: 10.1016/j.sjopt.2016.06.003. Epub 2016 Jun 28. Saudi J Ophthalmol. 2016. PMID: 28210175 Free PMC article.

6

The protective role of HSP27 in ocular diseases.

Sooraj K, Shukla S, Kaur R, Titiyal JS, Kaur J. Sooraj K, et al. Among authors: shukla s. Mol Biol Rep. 2022 Jun;49(6):5107-5115. doi: 10.1007/s11033-022-07222-6. Epub 2022 Feb 25. Mol Biol Rep. 2022. PMID: 35212927 Review.

7

An immunoinformatic approach for developing a multi-epitope subunit vaccine against Monkeypox virus.

Nayak AK, Chakraborty A, Shukla S, Kumar N, Samanta S. Nayak AK, et al. Among authors: shukla s. In Silico Pharmacol. 2024 May 12;12(1):42. doi: 10.1007/s40203-024-00220-5. eCollection 2024. In Silico Pharmacol. 2024. PMID: 38746047

8

Editorial: Pathogen targeting in chronic respiratory diseases: prevention, therapy and management.

Shukla SD, Dua K, O'Toole RF. Shukla SD, et al. Front Pharmacol. 2024 Apr 25;15:1407616. doi: 10.3389/fphar.2024.1407616. eCollection 2024. Front Pharmacol. 2024. PMID: 38725658 Free PMC article. No abstract available.

9

Exploring Novel Herbal Compounds and Formulations for Inflammatory Bowel Disease (IBD) Management.

Dubey RK, Shukla S. Dubey RK, et al. Among authors: shukla s. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2023 Dec 16;39:e20230003. doi: 10.62958/j.cjap.2023.003. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2023. PMID: 38716509 Free article. Review.

10

Clinical and Biochemical Characteristics of COVID-19-Associated Acute Kidney Injury (COVAKI): A Proof-of-Concept Case-Control Study.

Kumthekar GV, Nagarkar MS, Purandare V, Shukla S, Yeravdekar R. Kumthekar GV, et al. Among authors: shukla s. Cureus. 2024 Apr 7;16(4):e57763. doi: 10.7759/cureus.57763. eCollection 2024 Apr. Cureus. 2024. PMID: 38715992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,806 results

Search Page